Celgene files suit against Teva Pharmaceuticals over six patents related to a method of treating Attention Deficit Disorder and Attention Deficit Hyperactivity Disorder and the pharmaceutical unit dosage. 4/25, District of New Jersey, 2:2011cv02356.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
